The Vanderbilt Lung Institute is a clinical research site located in Nashville, Tennessee, United States 37204.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
The Vanderbilt Lung Institute has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Progressive Pulmonary Fibrosis, Interstitial Lung Disease.
Sponsors: United Therapeutics.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Vanderbilt Lung Institute has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Vanderbilt Lung Institute has 1 clinical trials on record, with 1 currently active. Their work covers Progressive Pulmonary Fibrosis, Interstitial Lung Disease.
The Vanderbilt Lung Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.